Which Pharma Product Websites are Driving Consumers to the Doctor to Request Prescriptions?

Manhattan Research’s ePharma Consumer® study provides in-depth info about pharma product websites and how consumers search and use prescription drug info online – free data snapshot offered below

NEW YORK--(BUSINESS WIRE)-- Pharmaceutical and healthcare market research company Manhattan Research recently released the ePharma Consumer® v10.0 study, which explores the online behaviors of ePharma Consumers, or U.S. consumers using the Internet for prescription drug information. The study also provides in-depth metrics for hundreds of pharma product websites, including satisfaction, reasons for visiting, and post-visitation actions, as well as adoption and interest for various types of online resources and services from pharma.

The study found that pharma product websites are effective at driving post-visitation action. 74%* of ePharma Consumers visiting these websites take a product-related action afterward – either discussing product info with their doctor, family or friends; requesting or filling the prescription; or searching for more product info online.

Among the more than 320 pharma product websites tracked in the study, the brand website of erectile dysfunction treatment Levitra® was the most likely to drive visitors to request a prescription for the drug from their doctor. The brand websites for Chantix®, Cialis®, Nexium®, and Yaz® round out the top five most likely to drive visitors to request prescriptions.

A common theme among top websites is content and structure designed to lead consumers to talk to their doctor. Additionally, many of these products, such as the sleep aid Lunesta® and the acid reflux treatment Nexium®, feature doctor discussion guides or worksheets on their websites.

Top Pharma Product Websites Driving Visitors to Request that Prescription from the Doctor

Rank

 

Brand

1.   Levitra®
2. Chantix®
3. Cialis®
4.

Nexium® (purplepill.com)

5. Yaz®
6. Lyrica®
7. NuvaRing®
8. Symbicort®
9. Viagra®
10. Lunesta®

Websites with the highest percent of visitors responding that they “requested a prescription for this product from a doctor” after visiting website for themselves; Among U.S. adults ages 18+ online for pharma information and websites for which n>60

*Industry average of aided responses across more than 320 product websites visited

Complimentary ePharma Consumer® Data Snapshot

If you’d like to download a complimentary one-page snapshot of data and insights from the ePharma Consumer® v10.0 study, please visit http://www.manhattanresearch.com/research/data-snapshots/epharma-consumer-data-snapshot.aspx.

About ePharma Consumer® v10.0

ePharma Consumer® v10.0 was fielded online in Q4 2010 among 6,606 U.S. adults (ages 18+) who have gone online for pharma or prescription drug information in the past 12 months. This year’s study also explores demand for adherence tools and services and the extent to which consumers leverage the Internet to lower drug spending. The study also provides key metrics for hundreds of pharma product websites.

For more information, please email [email protected], call 1.888.680.0800, ext 2, or visit http://www.manhattanresearch.com/epc.

About Manhattan Research

Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among healthcare professionals and consumers. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.



CONTACT:

Manhattan Research
Stephanie Cooper, 212-255-1368
[email protected]

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Technology  Internet  Health  Biotechnology  Pharmaceutical  General Health

MEDIA:

Logo
 Logo

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.